Recent Articles By The Author
The risk is that the chief design officer's departure will cause technical issues in Apple's chart.
The risk/reward ratio doesn't look good for retail investors.
The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.
The trouble for me, as an investor, is that this business remains in decline until it is not in decline.
Key to a China trade deal will be that both sides come away from the G-20 meeting with the feeling that progress has been made, and that the schedule of tariffs has not been expanded.
The deal makes sense for growth - and for Allergan shareholders - but now the price and uncertainty make this stock hard to swallow.
Plus, a look at Ulta Beauty and a possible options play in the retailer.
If I am going to tie up money in this deal, it would be only at a significant discount, and only from the ERI side.
Markets must choose now between the easy, the tense and the uncertain. What could possibly go wrong?